Redo Transcatheter Aortic Valve Replacement: Device Selection and Risks

Area of Science:

• Cardiology
• Interventional Cardiology
• Biomedical Engineering

Background:

• Transcatheter aortic valve replacement (TAVR) is standard for severe aortic valve disease in high-risk patients.
• Expanding TAVR use in younger populations increases the incidence of bioprosthetic valve failure (BVF).
• Effective long-term management strategies for BVF are increasingly necessary.

Purpose of the Study:

• To review the role of redo-TAVR, specifically the TAV-in-TAV approach, for managing BVF.
• To highlight challenges and technical considerations for TAV-in-TAV procedures.
• To emphasize the importance of preprocedural planning and multidisciplinary decision-making.

Main Methods:

• Review of current literature on TAV-in-TAV procedures for BVF.
• Discussion of technical aspects including valve selection, sizing, and implantation.
• Emphasis on advanced imaging (e.g., CT) for preprocedural planning.

Main Results:

• TAV-in-TAV is an evolving strategy for managing BVF.
• Key challenges include coronary obstruction, valve migration, and device selection.
• Advanced imaging and careful planning are crucial for minimizing complications.

Conclusions:

• Redo-TAVR, particularly TAV-in-TAV, shows promise for managing BVF.
• Optimizing techniques and device selection requires further research.
• A multidisciplinary heart team approach is essential for patient selection and procedural success.